Terns Pharmaceuticals



An emerging global leader in the development of molecularly-targeted drugs and combination therapies to treat liver diseases and liver cancer.

Diana Chung
VP, Clinical Development
Erin Quirk
President and CMO
Joy Zhou
VP, Clinical Development
Mark Vignola
Martijn Fenaux
VP, Research
Matt Duan
VP, Pharmaceutical Development
Weidong Zhong
CSO, Co-Founder, & Chairman
Bryan Yoon
Chief Operating Officer and General Counsel

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.